Voltage-Gated Potassium Channel (VGKC) Antibody with Reflex to LGI1 and CASPR2 Screen and Titer
Synonyms |
|
||||||||||||||||||||||||
Cerner Name |
|||||||||||||||||||||||||
Clinical Info |
Screening test for voltage-gated potassium channel (VGKC) antibody receptor complex-associated autoantibodies with test reflex to CASPR2 and LGI1 antibodies. Antibodies are associated with acquired neuromyotonia, limbic encephalitis, painful neuropathy, Morvan syndrome, and rare tumors (eg, thymoma, small-cell lung cancer). |
||||||||||||||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||||||||||||||
Specimen Types |
Blood |
||||||||||||||||||||||||
Specimen Volume |
4 mL serum ( 0.5 mL min) |
||||||||||||||||||||||||
Container |
Gold Top Tube |
||||||||||||||||||||||||
Collection Instructions |
Container/Tube: Gold To[ Tube |
||||||||||||||||||||||||
Transport Instructions |
Refrigerated |
||||||||||||||||||||||||
Specimen Stability |
3 Days Room Temperature |
||||||||||||||||||||||||
Methodology |
Quantitative Radioimmunoassay/Semi-Quantitative Indirect Fluorescent Antibody |
||||||||||||||||||||||||
Days Performed |
TAT 2 - 9 days Set up Tuesdays |
||||||||||||||||||||||||
Performing Laboratory |
ARUP Laboratories |
||||||||||||||||||||||||
CPT |
83519 |
||||||||||||||||||||||||
PDM |
1759386 |
||||||||||||||||||||||||
Only Orderable at Locations: |
Orderable Everywhere |
||||||||||||||||||||||||
Results |
|
||||||||||||||||||||||||
Result Interpretation
Voltage-Gated Potassium Channel (VGKC) Antibody
Negative 31 pmol or less Indeterminate 32 - 87 pmol/L Positive 88 pmol/L or greater Leucine-Rich, Glioma-Inactivated Protein 1 Antibody, IgG with Reflex to Titer Less than 1:10 Contactin-Associated Protein-2 Antibody, IgG with Reflex to Titer Less than 1:10 |
|||||||||||||||||||||||||
Forms |
|